Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Ascherio

Showing results (51-60 of 340) with videos related to

Pageof 34
Sort By:
Neurology|April 24, 2002
Caffeinated clues and the promise of adenosine A(2A) antagonists in PDMichael A Schwarzschild, Jiang-Fan Chen, Alberto Ascherio
Journal of Parkinson'S Disease|August 14, 2013
Declining quality of life in Parkinson disease before and after diagnosisNatalia Palacios, Xiang Gao, Michael Schwarzschild, et al.
Current Opinion in Neurology|March 12, 2021
Vaccinations in multiple sclerosis patients receiving disease-modifying drugsSusana Otero-Romero, Alberto Ascherio, Christine Lebrun-Frénay
JAMA|January 4, 2022
Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease-ReplyEric A Macklin, Alberto Ascherio, Michael A Schwarzschild
Current Opinion in Neurology|May 2, 2012
Vitamin D and multiple sclerosis: epidemiology, immunology, and geneticsKelly C Simon, Kassandra L Munger, Alberto Ascherio
Journal of the Neurological Sciences|October 7, 2011
XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?Kelly Claire Simon, Kassandra L Munger, Alberto Ascherio
The Lancet. Neurology|July 18, 2014
Urate and neuroprotection trialsMichael A Schwarzschild, Eric A Macklin, Alberto Ascherio, et al.
Nature Reviews. Neurology|October 10, 2012
The initiation and prevention of multiple sclerosisAlberto Ascherio, Kassandra L Munger, Jan D Lünemann
Neurology|March 9, 2018
Sun exposure over the life course and associations with multiple sclerosisHelen Tremlett, Feng Zhu, Alberto Ascherio, et al.
Annals of Epidemiology|May 10, 2011
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidenceNatalia Palacios, Alvaro Alonso, Henrik Brønnum-Hansen, et al.
Pageof 34

Showing results (51-60 of 340) with videos related to

Sort By:
Pageof 34
Neurology|April 24, 2002
Caffeinated clues and the promise of adenosine A(2A) antagonists in PDMichael A Schwarzschild, Jiang-Fan Chen, Alberto Ascherio
Journal of Parkinson'S Disease|August 14, 2013
Declining quality of life in Parkinson disease before and after diagnosisNatalia Palacios, Xiang Gao, Michael Schwarzschild, et al.
Current Opinion in Neurology|March 12, 2021
Vaccinations in multiple sclerosis patients receiving disease-modifying drugsSusana Otero-Romero, Alberto Ascherio, Christine Lebrun-Frénay
JAMA|January 4, 2022
Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease-ReplyEric A Macklin, Alberto Ascherio, Michael A Schwarzschild
Current Opinion in Neurology|May 2, 2012
Vitamin D and multiple sclerosis: epidemiology, immunology, and geneticsKelly C Simon, Kassandra L Munger, Alberto Ascherio
Journal of the Neurological Sciences|October 7, 2011
XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?Kelly Claire Simon, Kassandra L Munger, Alberto Ascherio
The Lancet. Neurology|July 18, 2014
Urate and neuroprotection trialsMichael A Schwarzschild, Eric A Macklin, Alberto Ascherio, et al.
Nature Reviews. Neurology|October 10, 2012
The initiation and prevention of multiple sclerosisAlberto Ascherio, Kassandra L Munger, Jan D Lünemann
Neurology|March 9, 2018
Sun exposure over the life course and associations with multiple sclerosisHelen Tremlett, Feng Zhu, Alberto Ascherio, et al.
Annals of Epidemiology|May 10, 2011
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidenceNatalia Palacios, Alvaro Alonso, Henrik Brønnum-Hansen, et al.
Pageof 34